No Data
No Data
Guoke Hengtai (301370.SZ) announced its 2023 annual results. Net profit of 154 million yuan increased 23.19% year over year
Guoke Hengtai (301370.SZ) released the 2023 annual results report. The company achieved operating income during the reporting period...
Guoke Hengtai (301370.SZ) completed the repurchase and spent 50.94 million yuan to repurchase 3.6359 million shares
Guoke Hengtai (301370.SZ) announced that the implementation of the company's share repurchase plan has been completed, as of April 1, 2024...
Guoke Hengtai (301370.SZ): Initial repurchase of 227,600 shares involving 3,026,95 million yuan
Gelonghui, March 27, 丨 Guoke Hengtai (301370.SZ) announced that on March 26, 2024, the company used its own funds to carry out the first repurchase through a special securities account for share repurchase through a centralized bidding transaction. The number of repurchases was 227,600 shares, accounting for 0.05% of the current total share capital. The highest transaction price was 13.45 yuan/share, the lowest transaction price was 13.17 yuan/share, and the total transaction amount was RMB 3,0269.53 million (excluding transaction fees).
GKHT Medical Technology Co., Ltd.'s (SZSE:301370) Market Cap Surged CN¥424m Last Week, Private Companies Who Have a Lot Riding on the Company Were Rewarded
Key Insights The considerable ownership by private companies in GKHT Medical Technology indicates that they collectively have a greater say in management and business strategy 55% of the business is
Guoke Hengtai (301370.SZ): relinquishment of priority transfer rights for 40% of the holding subsidiary Sichuan Guoke
Guoke Hengtai (301370.SZ) announced that the company's holding subsidiary, Sichuan Guoke Hengrui Medical Technology Co., Ltd. (“...
Guoke Hengtai (301370.SZ) plans to establish 4 new wholly-owned subsidiaries in Henan and other places
Guoke Hengtai (301370.SZ) announced that the company plans to separate in Henan Province, Hebei Province, Liaoning Province, Hainan Province, etc...
No Data